Regeneron Pharmaceuticals, Inc. (REGN) Presents At Cantor Global Healthcare Conference 2025 (Transcript)

Core Insights - Regeneron participated in the Cantor Global Healthcare Conference, highlighting its presence in the biopharma sector [1][2] - The company’s CFO, Chris Fenimore, and Senior Vice President of Investor Relations & Strategic Analysis, Ryan Crowe, represented Regeneron during the event [1][2] Company Overview - Regeneron is focused on large-cap biopharma, indicating its significant market position and influence within the industry [1] - The company is committed to transparency, as evidenced by its mention of forward-looking statements and associated risks [2] Strategic Communication - The remarks made during the conference included forward-looking statements, which are subject to various risks and uncertainties [2] - Regeneron emphasized that it does not have an obligation to update forward-looking statements, reflecting a cautious approach to investor communications [2]